Cellebrite DI Q1 2024 Adj EPS $0.08 Beats $0.06 Estimate, Sales $89.582M Beat $87.757M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cellebrite DI (NASDAQ:CLBT) reported Q1 2024 earnings of $0.08 per share, beating the analyst estimate of $0.06 by 33.33%. Sales were $89.582 million, surpassing the $87.757 million estimate and marking a 25.76% increase from the same period last year.
May 23, 2024 | 11:03 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cellebrite DI reported strong Q1 2024 earnings and sales, significantly beating analyst estimates. This positive performance is likely to boost investor confidence and drive the stock price up in the short term.
The company's earnings per share of $0.08 beat the analyst estimate by 33.33%, and sales of $89.582 million surpassed the estimate by 2.08%. Both metrics showed significant year-over-year growth, indicating strong financial health and performance, which is likely to positively impact the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100